Page last updated: 2024-08-24

sertraline and Candidiasis, Vulvovaginal

sertraline has been researched along with Candidiasis, Vulvovaginal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dierich, MP; Fuchs, D; Lass-Flörl, C; Ledochowski, M; Semenitz, E1

Other Studies

1 other study(ies) available for sertraline and Candidiasis, Vulvovaginal

ArticleYear
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Dec-15, Volume: 33, Issue:12

    Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline

2001